Drug testing in oral fluid-evaluation of sample collection devices
Langel K., Engblom C., Pehrsson A., Gunnar T., Ariniemi K., Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol 2008, 32:393-401.
ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007
Ventura M., Ventura R., Pichini S., et al. ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007. Forensic Sci Int 2008, 182:35-40.
Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes
Ventura M., Pichini S., Ventura R., et al. Stability of drugs of abuse in oral fluid collection devices with purpose of external quality assessment schemes. Ther Drug Monit 2009, 31:277-280.
Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs
Wille S.M., Raes E., Lillsunde P., et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit 2009, 31:511-519.
Degradation and racemization of zopiclone enantiomers in plasma and partially aqueous solutions
Fernandez C., Gimenez F., Mayrargue J., Thuillier A., Farinotti R. Degradation and racemization of zopiclone enantiomers in plasma and partially aqueous solutions. Chirality 1995, 7:267-271.
Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection
Mannaert E., Tytgat J., Daenens P. Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection. J Anal Toxicol 1997, 21:208-212.